Edition:
United Kingdom

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

73.95GBp
11 Dec 2018
Change (% chg)

2.00 (+2.78%)
Prev Close
71.95
Open
72.30
Day's High
75.25
Day's Low
72.30
Volume
1,079,256
Avg. Vol
1,218,479
52-wk High
127.22
52-wk Low
65.85

Select another date:

Mon, Nov 26 2018

Vectura drops severe asthma treatment after poor trial results

Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.

Vectura drops severe asthma treatment after poor trial results

Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.

UPDATE 2-Vectura drops severe asthma treatment after poor trial results

* Shares fall more than 10 percent (Adds CEO, analyst comment, share movement)

Vectura to stop developing asthma treatment after late-stage failure

Nov 26 British drugmaker Vectura Group Plc said on Monday it would stop developing its treatment for severe uncontrolled asthma after the drug-device combination failed to meet the main goal of a late-stage study.

UPDATE 1-Vectura reviewing drug stockpiles as no-deal Brexit looms

Sept 11 British drugmaker Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its mitigation plan for a "no-deal" Brexit and warned on Tuesday of a potential disruption to supply chains and higher costs.

Vectura reviewing drug stockpiles as no-deal Brexit looms

Sept 11 Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its plan for a "no-deal" Brexit, the British drugmaker said on Tuesday, and warned of a potential disruption to supply chains and higher costs.

Select another date: